Skip to main content
SpringerLink
Log in

New style clinical trials in schizophrenia

  • Clinical Trials Review
  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Meltzer HY: Clozapine: is another view valid [editorial]? Am J Psychiatry 1995, 152:821–825.

    PubMed  CAS  Google Scholar 

  2. Carpenter WT, Conley RR, Buchanan RW, et al.: Patient response and resource management: another view of clozapine treatment of schizophrenia. Am J Psychiatry 1995, 152:827–832.

    PubMed  Google Scholar 

  3. Carpenter WT, Conley RR, Buchanan RW, et al.: Clozapine conflict [letter to Editor in rebuttal to editorial by Meltzer H, Am J Psychiatry 1995, 152:821-825]. Am J Psych 1996,153:1505–1507.

    Google Scholar 

  4. Tandon R, Goldman R, DeQuardo JR, et al.: Positive and negative symptoms co-vary during clozapine treatment in schizophrenia. J Psychiatric Res 1993, 27:341–347.

    Article  Google Scholar 

  5. Conley R, Richardson C, Kent D, et al.: Clozapine responses varies in deficit vs. non-deficit schizophrenic subjects [abstract]. Biol Psychiatry 1994, 35(9):746.

    Article  Google Scholar 

  6. Lieberman JA, Safferman AZ, Pollack S, et al.: Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome. Am J Psychiatry 1994, 151(2):1744–1752.

    PubMed  CAS  Google Scholar 

  7. Buchanan RW, Breier A, Kirkpatrick B, et al.: Positive and negative symptom response to clozapine in schizophrenic patients with and without deficit syndrome. Am J Psychiatry 1998, 155(6):751–760.

    PubMed  CAS  Google Scholar 

  8. Rosenheck R, Dunn L, Peszke M, et al.: Impact of clozapine on negative symptoms and on the deficit syndrome in refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Am J Psychiatry 1999, 156(1):88–93.

    PubMed  CAS  Google Scholar 

  9. Schooler N, Marder S, Kane J, et al.: Clozapine and risperidone: a 29-week randomized clinical trial [abstract]. Schizophren Res 1999, 36(1-3):296.

    Google Scholar 

  10. Wahlbeck K, Cheine M, Essali A, Adams C: Evidence of clozapine’s effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials. Am J Psychiatry 1999, 156(7):990–999.

    PubMed  CAS  Google Scholar 

  11. Carpenter WT: Psychopathology and common sense: where we went wrong with negative symptoms [editorial]. Biol Psychiatry 1991, 29:735–737.

    Article  PubMed  Google Scholar 

  12. Carpenter WT: The deficit syndrome [editorial]. Am J Psychiatry 1994, 151:327–329.

    PubMed  Google Scholar 

  13. Javitt DC, Zylberman I, Zukin SR, et al.: Amelioration of negative symptoms in schizophrenia by glycine. Am J Psychiatry 1994, 151:1234–1236.

    PubMed  CAS  Google Scholar 

  14. Goff DC, Tsai G, Manoach DS, Coyle JT: Dose-finding trial of d-cycloserine added to neuroleptics for negative symptoms in schizophrenia. Am J Psychiatry 1995, 152:1213–1215.

    PubMed  CAS  Google Scholar 

  15. Heresco-Levy U, Javitt DC, Ermilov M, et al.: Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia. Br J Psychiatry 1996, 169:610–617.

    Article  PubMed  CAS  Google Scholar 

  16. Goff DC, Tsai G, Levitt J, et al.: A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch Gen Psychiatry 1999, 56:21–27.

    Article  PubMed  CAS  Google Scholar 

  17. Heresco-Levy U, Javitt DC, Ermilov M, et al.: Efficacy of highdose glycine in the treatment of enduring negative symptoms of schizophrenia. Arch Gen Psychiatry 1999, 56:29–36.

    Article  PubMed  CAS  Google Scholar 

  18. Tsai G, Yang P, Chung L-C, et al.: D-serine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry 1998, 44:1081–1089.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Maryland Psychiatric Research Center, University of Maryland School of Medicine, PO Box 21247, 21228, Baltimore, MD, USA

    William T. Carpenter MD

Authors
  1. William T. Carpenter MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carpenter, W.T. New style clinical trials in schizophrenia. Curr Psychiatry Rep 1, 11–12 (1999). https://doi.org/10.1007/s11920-999-0004-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-999-0004-2

Keywords

Search

Navigation